Redefining the Role of Cardiologists in the Management of Type 2 Diabetes: Best Practices for Cardiovascular Risk Reduction Evaluation (ID: i735a) Survey

Question Title

* 1. How many patients with Type 2 Diabetes Mellitus (T2DM) who have or are at risk for developing cardiovascular disease (CVD) do you currently manage in your practice? Please respond with your best approximate number.

Question Title

* 2. How confident are you in your ability to manage these patients?

Very confident

Confident

Neutral

Unconfident

Very unconfident

Question Title

* 3. How many years have you been in practice?

1-10

11-20

≥21

Question Title

* 4. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information that I can apply to my area of practice

I need more information before I change my practice behavior

This activity will not change my practice, as my current practice is consistent with the

information presented

This activity will not change my practice.

Question Title

* 5. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes.

Question Title

* 6. After participating in today’s activity, I am now able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Portray the burdens associated with cardiovascular disease in patients with T2DM	Portray the burdens associated with cardiovascular disease in patients with T2DM Strongly agree	Portray the burdens associated with cardiovascular disease in patients with T2DM Agree	Portray the burdens associated with cardiovascular disease in patients with T2DM Neutral	Portray the burdens associated with cardiovascular disease in patients with T2DM Disagree	Portray the burdens associated with cardiovascular disease in patients with T2DM Strongly disagree
Integrate data from cardiovascular outcome trials into the management of patients with T2DM to improve cardiovascular outcomes	Integrate data from cardiovascular outcome trials into the management of patients with T2DM to improve cardiovascular outcomes Strongly agree	Integrate data from cardiovascular outcome trials into the management of patients with T2DM to improve cardiovascular outcomes Agree	Integrate data from cardiovascular outcome trials into the management of patients with T2DM to improve cardiovascular outcomes Neutral	Integrate data from cardiovascular outcome trials into the management of patients with T2DM to improve cardiovascular outcomes Disagree	Integrate data from cardiovascular outcome trials into the management of patients with T2DM to improve cardiovascular outcomes Strongly disagree
Examine recently updated clinical guidelines including the 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease	Examine recently updated clinical guidelines including the 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease Strongly agree	Examine recently updated clinical guidelines including the 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease Agree	Examine recently updated clinical guidelines including the 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease Neutral	Examine recently updated clinical guidelines including the 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease Disagree	Examine recently updated clinical guidelines including the 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease Strongly disagree
Incorporate effective multidisciplinary care strategies into clinical practice to ensure a continuum of care for patients with T2DM	Incorporate effective multidisciplinary care strategies into clinical practice to ensure a continuum of care for patients with T2DM Strongly agree	Incorporate effective multidisciplinary care strategies into clinical practice to ensure a continuum of care for patients with T2DM Agree	Incorporate effective multidisciplinary care strategies into clinical practice to ensure a continuum of care for patients with T2DM Neutral	Incorporate effective multidisciplinary care strategies into clinical practice to ensure a continuum of care for patients with T2DM Disagree	Incorporate effective multidisciplinary care strategies into clinical practice to ensure a continuum of care for patients with T2DM Strongly disagree

Question Title

* 7. Silvio Inzucchi, MD, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias	Avoided commercial bias Strongly agree	Avoided commercial bias Agree	Avoided commercial bias Neutral	Avoided commercial bias Disagree	Avoided commercial bias Strongly disagree

Question Title

* 8. Mikhail Kosiborod, MD, FACC, FAHA, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias	Avoided commercial bias Strongly agree	Avoided commercial bias Agree	Avoided commercial bias Neutral	Avoided commercial bias Disagree	Avoided commercial bias Strongly disagree

Question Title

* 9. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Redefining the Role of Cardiologists in the Management of Type 2 Diabetes: Best Practices for Cardiovascular Risk Reduction Evaluation (ID: i735a)

Question Title

* 1. How many patients with Type 2 Diabetes Mellitus (T2DM) who have or are at risk for developing cardiovascular disease (CVD) do you currently manage in your practice? Please respond with your best approximate number.

Question Title

* 2. How confident are you in your ability to manage these patients?

Question Title

* 3. How many years have you been in practice?

Question Title

* 4. Which of the following best describes the impact of this activity on your performance?

Question Title

* 5. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 6. After participating in today’s activity, I am now able to:

Question Title

* 7. Silvio Inzucchi, MD, effectively:

Question Title

* 8. Mikhail Kosiborod, MD, FACC, FAHA, effectively:

Question Title

* 9. The content presented:

Question Title

* 10. As a result of your participation in this activity, what strategies/changes do you plan to implement in your practice?

Question Title

* 11. What barriers do you see to making changes in your practice?

Question Title

* 12. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 13. If you indicated that you perceived commercial bias or influence, please describe: